Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Expected to Post Quarterly Sales of $129.44 Million

Retrieved on: 2021-06-04 21:39:50

Tags for this article:

Click the tags to see associated articles and topics

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Expected to Post Quarterly Sales of $129.44 Million. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 6,117,166 shares of the biopharmaceutical company's stock valued at $156,417,000 after buying an additional 82,437 shares ...

Article found on: www.marketbeat.com